The new rule was contained within a larger proposal to ensure contraceptive coverage in the face of Republican attacks.

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

The Biden-Harris administration announced Monday a new requirement for insurance providers to cover injectable PrEP in their ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

An analysis by Li Tao, MD, MS, PhD, director of real-world evidence at Gilead Sciences, and colleagues looked at statistical ...

Learn about the changing trend in pre exposure prophylaxis medication prescription for HIV patients in the US over the past ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...

This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...